Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?

Overview of attention for article published in Journal of Clinical Investigation, December 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 64,400 followers.

RT @jclinicalinvest: Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy? https://t.c…

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy? https://t.co/EtIl0ExNyR A #Commentary by Nahuel Peinetti, @mbilusic & Kerry L. Burnstein @SylvesterCancer Related: https://t.co/whWVk7J41T…

An excellent commentary on AR activity in metastatic PCa in @jclinicalinvest. It discusses Sena et al. article on phase II clinical trial-enrolled patients with metastatic CRPC. https://t.co/M1udoi0DZi

RT @DavidESanin: Awesome to see @laurasenamd's work highlighted in @jclinicalinvest! (https://t.co/eJSvnRKZDh) So happy to have been part o…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.